<!doctype html><html><head><meta charset=utf-8><title>NAFLD in children nicely treated by combination of Vitamin D and Omega-3 – RCT</title>
<link rel=stylesheet href="/css/main.css?v=1752030347"><link rel=stylesheet href="/css/pagination.css?v=1752030347"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1752030347"></script><script src="/js/search.js?v=1752030347"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>NAFLD in children nicely treated by combination of Vitamin D and Omega-3 – RCT</h1><time>July 8, 2017</time><div data-pagefind-body><h4 id=docosahexanoic-acid-plus-vitamin-d-treatment-improves-features-of-nafld-in-children-with-serum-vitamin-d-deficiency-results-from-a-single-centre-trial>Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.</h4><p>PLoS One. 2016 Dec 15;11(12):e0168216. <a href=https://doi.org/10.1371/journal.pone.0168216.>doi: 10.1371/journal.pone.0168216.</a> eCollection</p><div class=border style="background-color:#ff9;padding:15px;margin:10px 0;border-radius:5px;width:750px"><p><strong>RCT of 40 obese children, 500 mg of DHA, 800 IU of vitamin D, 1 year</strong></p><p><strong>DHA only helped some, DHA + Vitamin D was much better</strong></p><h4 id=see-also-vitamindwiki>See also VitaminDWiki</h4><ul><li><p><a href=/posts/strong-association-of-non-alcoholic-fatty-liver-disease-and-low-vitamin-d>Strong association of non alcoholic fatty liver disease and low vitamin D</a> many studies</p></li><li><p><a href=/posts/severe-non-alcoholic-fatty-liver-disease-treated-by-omega-3-rct>Severe Non-Alcoholic fatty liver disease treated by Omega-3 – RCT April 2018</a></p></li><li><p><a href=/posts/non-alcoholic-fatty-liver-disease-nafld-treated-by-vitamin-d-20000-iu-weekly-after-loading-dose-rct>Non-Alcoholic Fatty Liver Disease (NAFLD) treated by Vitamin D (20,000 IU weekly after loading dose) – RCT June 2016</a> many studies</p></li><li><p><a href=/posts/non-alcoholic-fatty-liver-disease-treated-by-omega-3-meta-analysis>Non-Alcoholic Fatty Liver Disease treated by Omega-3 – meta-analysis Oct 2016</a></p></li><li><p><a href=/posts/non-alcoholic-fatty-liver-disease-nafld-reduced-somewhat-by-50000-iu-vitamin-d-every-2-weeks-rct>Non-alcoholic fatty liver disease (NAFLD) reduced somewhat by 50,000 IU vitamin D every 2 weeks – RCT Sept 2014</a></p></li><li><p><a href=/posts/liver-inflammation-nafld-is-prevented-by-vitamin-d-review>Liver Inflammation (NAFLD) is prevented by Vitamin D – review May 2015</a></p></li></ul></div><p><strong><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/nafld-vitd-omega-3.pdf>Download the PDF from VitaminDWiki</a></strong></p><p>Della Corte C1, Carpino G2, De Vito R3, De Stefanis C4, Alisi A4, Cianfarani S5, Overi D6, Mosca A1, Stronati L7, Cucchiara S8, Raponi M9, Gaudio E6, Byrne CD10,11, Nobili V1,4.</p><img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/nafld-t4.jpg alt=image width=600>
<img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/nafld-t5.jpg alt=image width=800><p>BACKGROUND:</p><p>There are no licensed treatments for non alcoholic fatty liver disease (NAFLD) in adults or children. In NAFLD, several studies have shown a benefit of omega-3 fatty acid treatment on lipid profile, insulin-sensitivity and hepatic steatosis and it has also been suggested that Vitamin D treatment has potential antifibrotic properties in liver disease.</p><p>TRIAL DESIGN:</p><p>To date, however, there are no studies that have tested the combination of Docosahexanoic acid (DHA) and vitamin D treatment which may benefit the whole spectrum of disease in NAFLD. Our aim therefore, was to test the effect of daily DHA (500 mg) plus vitamin D (800 IU) treatment, in obese children with biopsy-proven NAFLD and vitamin D deficiency, in a randomized, double-blind placebo-controlled trial.</p><p>METHODS:</p><p>The 41/43 patients completed the study (18-treatment, 23-placebo). At 12 months: i) the main outcome was liver histology improvement, defined by NAS; ii) the secondary outcome was amelioration of metabolic parameters.</p><p>RESULTS:</p><p>DHA plus vitamin D treatment reduced the NAFLD Activity Score (NAS), in the treatment group (5.4 v1.92; p&lt;0.001 for baseline versus end of study). There was no change in fibrosis score, but a reduction of the activation of hepatic stellate cells (HSC) and fibrillar collagen content was noted (3.51±1.66 v. 1.59±1.37; p = 0.003) in treatment group. Moreover, the triglycerides (174.5 vs. 102.15 mg/dl), ALT (40.25 vs. 24.5 UI/l) and HOMA-IR (4.59 vs. 3.42) were all decreased with treatment.</p><p>CONCLUSION:</p><p>DHA plus vitamin D treatment improved insulin-resistance, lipid profile, ALT and NAS. There was also decreased HSC activation and collagen content with treatment.</p></div><hr class=tag-separator><div class=tags><span>Tags: </span><span class=tag>child</span>
<span class=tag>dosage</span>
<span class=tag>high dose</span>
<span class=tag>Infant-Child</span>
<span class=tag>Intervention</span>
<span class=tag>liver</span>
<span class=tag>Liver</span>
<span class=tag>NAFLD</span>
<span class=tag>Obesity</span>
<span class=tag>omega 3</span>
<span class=tag>therapeutic intervention</span>
<span class=tag>vitamin d</span>
<span class=tag>Vitamin D and Omega-3</span></div><div data-pagefind-meta=tags hidden>child, dosage, high dose, Infant-Child, Intervention, liver, Liver, NAFLD, Obesity, omega 3, therapeutic intervention, vitamin d, Vitamin D and Omega-3</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1752030347"></script><script src="/js/tiki-redirects.js?v=1752030347"></script><script src="/js/lightspa.js?v=1752030347"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1752030347",indexUrl:"/search/search_index.json.gz?v=1752030347"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1752030347"></script></body></html>